Biological Products, (No Diagnostic Substances) · V8 · CIK 1674416
Develops CRISPR-based gene therapies for serious human diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 23, 2026: 4 sold $12.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2026 | Kulkarni SamarthChief Executive Officer | Sell | 10,020 | $46.78 | $469K |
| Mar 23, 2026 | Prasad RajuChief Financial Officer | Sell | 3,708 | $46.78 | $173K |
| Mar 23, 2026 | Kasinger James R.General Counsel and Secretary | Sell | 3,182 | $46.78 | $149K |
| Mar 16, 2026 | Kulkarni SamarthChief Executive Officer | Sell | 10,349 | $48.26 | $499K |
| Mar 16, 2026 | Prasad RajuChief Financial Officer | Sell | 5,848 | $48.26 | $282K |
| Mar 16, 2026 | Prasad RajuChief Financial Officer | Sell | 4,021 | $48.26 | $194K |
| Mar 16, 2026 | Kasinger James R.General Counsel and Secretary | Sell | 3,450 | $48.26 | $166K |
| Mar 16, 2026 | Patel NaimishChief Medical Officer | Sell | 3,150 | $48.26 | $152K |
| Mar 11, 2026 | Kulkarni SamarthChief Executive Officer | Sell | 9,798 | $52.80 | $517K |
| Mar 11, 2026 | Kasinger James R.General Counsel and Secretary | Sell | 2,800 | $52.80 | $148K |
| Feb 19, 2026 | Kulkarni SamarthChief Executive Officer | Sell | 6,967 | $52.58 | $366K |
| Feb 19, 2026 | Kasinger James R.General Counsel and Secretary | Sell | 2,112 | $52.58 | $111K |
| Jan 22, 2026 | Kulkarni SamarthChief Executive Officer | Sell | 60,000 | $60.23 | $3.6M |
| Jan 22, 2026 | Prasad RajuChief Financial Officer | Sell | 34,972 | $60.19 | $2.1M |
| Jan 20, 2026 | Kulkarni SamarthChief Executive Officer | Sell | 21,433 | $51.61 | $1.1M |
| Jan 20, 2026 | Kulkarni SamarthChief Executive Officer | Sell | 8,567 | $52.10 | $446K |
| Jan 6, 2026 | Prasad RajuChief Financial Officer | Sell | 18,933 | $60.18 | $1.1M |
| Jan 6, 2026 | Prasad RajuChief Financial Officer | Sell | 5,763 | $60.21 | $347K |
| Jan 6, 2026 | Prasad RajuChief Financial Officer | Sell | 5,004 | $60.00 | $300K |
| Dec 22, 2025 | Prasad RajuChief Financial Officer | Sell | 5,472 | $56.33 | $308K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Coverage (30d): 1 reputable article · skews ▲ positive.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗